-
1
Asia–Pacific Real-World Evolocumab Use, LDL-C Reduction, Physician Goals, and Patient Perceptions: HALES Observational Study
Published 2024-10-01“…Cardiology and Therapy…”
Get full text
Article -
2
Real-World Application of Evolocumab Among Patients with Hyperlipidemia in Korea: A Multicenter Prospective Study
Published 2024-10-01“…Cardiology and Therapy…”
Get full text
Article -
3
Expert Opinion on the Role of Sacubitril/Valsartan in the Management of Hypertension in India
Published 2024-11-01“…Cardiology and Therapy…”
Get full text
Article -
4
Milvexian: An Oral, Bioavailable Factor XIa Inhibitor
Published 2024-08-01“…Cardiology and Therapy…”
Get full text
Article -
5
National Trends in Aspirin Use and Expenditures in the United States: Analysis of The Medical Expenditure Panel Survey 2000–2021
Published 2024-10-01“…Cardiology and Therapy…”
Get full text
Article -
6
Sodium Zirconium Cyclosilicate for Renin–Angiotensin–Aldosterone System Inhibitor Optimization in Patients with Heart Failure with Reduced Ejection Fraction: A Retrospective Analys...
Published 2024-11-01“…Cardiology and Therapy…”
Get full text
Article -
7
Macitentan in Pulmonary Arterial Hypertension Due to Congenital Heart Disease (CHD-PAH): Real-World Evidence from the OPUS/OrPHeUS Studies
Published 2024-11-01“…Cardiology and Therapy…”
Get full text
Article -
8
Letter to the Editor Regarding ‘Tafamidis 61 mg Patient Characteristics and Persistency? A Retrospective Analysis of German Statutory Health Insurance Data (IQVIA™ LRx)’
Published 2024-10-01“…Cardiology and Therapy…”
Get full text
Article -
9
Predictors and Outcomes of Inappropriate Dosing of Direct Oral Anticoagulants in Patients Receiving Transcatheter Aortic Valve Implantation
Published 2024-11-01“…Cardiology and Therapy…”
Get full text
Article -
10
A Response to: Letter to the Editor Regarding “Tafamidis 61 mg Patient Characteristics and Persistency? A Retrospective Analysis of German Statutory Health Insurance Data (IQVIA™ L...
Published 2024-10-01“…Cardiology and Therapy…”
Get full text
Article -
11
ACE Inhibitors and Angiotensin Receptor Blockers for the Primary and Secondary Prevention of Cardiovascular Outcomes: Recommendations from the 2024 Egyptian Cardiology Expert Conse...
Published 2024-10-01“…Cardiology and Therapy…”
Get full text
Article